TerminatedNot applicableNCT00006054
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
Studying Syndromic oculocutaneous albinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fairview University Medical Center
- Principal Investigator
- K. Scott BakerFairview University Medical Center
- Intervention
- anti-thymocyte globulin(drug)
- Eligibility
- 35 years · All sexes
- Timeline
- 2000 – 2002
Study locations (1)
- Fairview University Medical Center, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006054 on ClinicalTrials.govOther trials for Syndromic oculocutaneous albinism
Additional recruiting or active studies for the same condition.